Search

Filters

Clear Filters
2:45 PM - 2:55 PM ET

130 - Growth Trajectory following Vertebral Body-Sparing Proton Craniospinal Irradiation in Pediatric Patients
Speaker: Daniels, Kristin, BS - UC San Diego School of Medicine, La Jolla, CA
10:57 AM - 11:00 AM ET

130 - Growth Trajectory following Vertebral Body-Sparing Proton Craniospinal Irradiation in Pediatric Patients
Speaker: Daniels, Kristin, BS - UC San Diego School of Medicine, La Jolla, CA
2:55 PM - 3:00 PM ET

131 - Subsequent Tumors Following Pencil Beam Scanning Proton Radiotherapy
Speaker: Lucas, John, MD, MS - St. Jude Children's Research Hospital, Memphis, TN
10:54 AM - 10:57 AM ET

131 - Subsequent Tumors Following Pencil Beam Scanning Proton Radiotherapy
Speaker: Lucas, John, MD, MS - St. Jude Children's Research Hospital, Memphis, TN
5:00 PM - 5:10 PM ET

132 - Long-Term Outcomes from a Phase 2 Trial of Stereotactic Ablative Radiotherapy (SAbR) for Primary Renal Cell Carcinoma
Speaker: Li, Xingzhe, MD, MPH - UT Southwestern Medical Center, Dallas, TX
5:10 PM - 5:20 PM ET

133 - Efficacy and Safety of Targeted-Immunotherapy with or without Stereotactic Ablative Radiotherapy for Recurrent/Metastatic Renal Cell Carcinoma: The Result of a Multicenter Ambidirectional cohort study
Speaker: Hu, Ke, MD - Peking University First Hospital, Beijing, Beijing
5:20 PM - 5:30 PM ET

134 - Safety and Efficacy of Stereotactic Body Radiotherapy (SBRT) for Localized Renal Pelvic and Ureteral Carcinoma
Speaker: Li, Xiaoying, MD - Peking University First Hospital, Beijing, Beijing
5:30 PM - 5:40 PM ET

135 - Evaluation of 68Ga-NYM 096 CAIX PET/CT for Systemic Therapy-Radiotherapy Integration and Target Definition in Metastatic ccRCC (NYCRRT)
Speaker: Ma, Mingwei, MD - Peking University First Hospital, Beijing, Beijing
5:40 PM - 5:50 PM ET

136 - Locoregional Recurrence in pT3-4/pN+ Muscle-Invasive Bladder Cancer Receiving Modern Perioperative Systemic Therapy: A Propensity Score-Matched Competing Risk Analysis
Speaker: Cheng, Tian, MD, MBBS - Peking University First Hospital, Beijing, Beijing
5:50 PM - 6:00 PM ET

137 - Adaptive Radioresistance in Muscle-Invasive Bladder Cancer Is Driven by Tumour-Microenvironment Co-Evolution and Enables Biomarker-Guided Radiotherapy
Speaker: Choudhury, Ananya, PhD, MA MRCP FRCR - The Christie NHS Foundation Trust and University of Manchester, Manchester, Greater Manchest
5:00 PM - 5:10 PM ET

138 - State Paid Family Leave Policies, Informal Family Caregivers and Cancer Mortality among Older Adults
Speaker: Barnes, Justin, MD, MS - Mayo Clinic Alix School of Medicine, Rochester, MN
5:10 PM - 5:20 PM ET

139 - Characterization of Laboratory Eligibility Criteria In Phase III Oncology Trials: A Meta-Epidemiological Analysis
Speaker: Pocha, Olivia, MS, BS - Tulane University School of Medicine, New Orleans, LA